Hepatic toxicity during the intensive asparaginase course was seen in 33 patients (53%), including 10 patients who developed grade 3 or 4 hyperbilirubinemia, 3 patients who had liver dysfunction ...

UIC researchers have redesigned asparaginase, a key leukemia treatment, to reduce severe side effects like liver damage and ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.